Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities

NCT06399029 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Exanthema
Lichenoid Skin Rashes Under Anti-PD1 Tumor Therapy

Interventions

DRUG: Ruxolitinib Topical Cream

Sponsor

University of Zurich

Collaborators

[object Object]